Blue Matter is a strategic consulting firm serving the life sciences industry. Its clients include leading pharmaceutical and biotech companies from around the globe. Blue Matter helps clients maximize value at the product, portfolio, and organizational levels.
The firm specializes in developing corporate strategy, as well as commercial strategies for pre-launch and launch-stage pharmaceutical and biotech products. However, it also assists clients with in-line (marketed) products. The firm is organized into centers of excellence, each of which focuses on a critical aspect of corporate, portfolio, or product strategy.
Its Market Access center of excellence has teams across Europe and North America and offers market-specific expertise in market access landscape assessment, pricing and market access strategy, engagement strategy, and more.
Blue Matter performs work in a range of therapeutic areas, but offers in-depth expertise in complex markets such as oncology, CNS, and rare diseases. It brings a wealth of experience with the latest innovations in medicine, including cell and gene therapies.